TREACE JOHN T. (Chief Executive Officer) purchased 5.2% of their position (300K shares) of TREACE MEDICAL CONCEPTS, INC. on the open market
Open‑market purchase worth $1.37M — a moderate purchase. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 5/13/2024ACC: 0000950170-24-058878
DirectorOfficer10% Owner· Chief Executive Officer
Since Apr 2021
+300K
Net shares
Net buyer
$1.37M
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
300K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+150K
Price / share
$4.58
Trade value
$686.88K
% of position
2.6%
5/10/2024
5.79M→5.94M
Common Stock
Direct
Shares
+150K
Price / share
$4.56
Trade value
$683.49K
% of position
2.5%
5/13/2024
5.94M→6.09M
Total
Net shares
+300K
Net value
$1.37M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/10/2024 | P · Purchase | +150K | $4.58 | $686.88K | 2.6% | 5.79M | 5.94M |
| Common Stock Direct | 5/13/2024 | P · Purchase | +150K | $4.56 | $683.49K | 2.5% | 5.94M | 6.09M |
| Total | +300K | $1.37M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned408.82K
Common Stock
IndirectShares owned1.60M
Common Stock
IndirectShares owned1.84M
Common Stock
IndirectShares owned1.47M
Total
5.32M indirect5.32M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 408.82K | Indirect |
| Common Stock | 1.60M | Indirect |
| Common Stock | 1.84M | Indirect |
| Common Stock | 1.47M | Indirect |
| Total | 5.32M | 5.32M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported